MedNet Portal | |
H1 tags : MedNet Portal | |
H2 tags : Simplifying Monitoring with Oral Anticoagulants; Lessons on Optimizing 5-ASA Therapy and Bowel Preparation; Novel Adjuvant in Trivalent Inactivated Influenza Vaccine for Very Young Children; Hyponatremia in the Hospital Setting; Pulmonary Arterial Hypertension: Addressing the Challenge of Early Diagnosis and Treatment; Differences Between Anticoagulants in Percutaneous Coronary Procedures; New Evidence that Glucose Control in Diabetes Offers Greater Protection Against CV Events and the CV Safety of Investigational Diabetes Agents; Rapid Treatment Response in Rheumatoid Arthritis: A Valuable Indicator of Reduced Risk of Joint Damage; Non-TNF Inhibitor Biologics: Expanding Opportunities for Rheumatoid Arthritis Control; Novel Oral Inhibitors of Select Enzymatic Pathways in Rheumatoid Arthritis Inflammation; Interleukin-1 Inhibitors in Specific Rheumatoid Diseases; Sequencing Biologic Therapeutic Strategies in Rheumatoid Diseases; Asthma Management: The Goal Is Control; Proton Pump Inhibitor Use in Patients on Antiplatelet Therapies: A Consensus Approach to Risk Management; Canadian Interventional Cardiology Guidelines Recognizing Outcome Benefits of Newer Antiplatelet Strategies; HDL-C Mechanisms for CV Risk Management: Quality over Quantity; VACCINE; Progress in Pneumococcal Vaccine Development; Partnering with Patients on Hemodialysis: Nursing Support, Advocacy and Skills; The Promise of Oral MS Therapies Weighed Against the Defined Benefits of Established Agents |
Last Update : | 04/January/2012 |
Google PR : | N/A |
Internal links : | 72 |
External links : | 2 |
Archive : | Check how did the site look in the past? |